BioMarin Pharmaceutical Inc. (FRA:BM8)
Germany · Delayed Price · Currency is EUR 47.08
+0.02 (0.04%)
At close: Jan 30, 2026
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of €9.14 billion as of January 30, 2026. Its market cap has decreased by -19.85% in one year.
Market Cap
9.14B
Enterprise Value
8.41B
Revenue
2.64B
Ranking
n/a
PE Ratio
20.61
Stock Price
€47.08
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 425.62M to 9.14B, an increase of 2,048.08%. That is a compound annual growth rate of 12.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 9.14B | -5.98% |
| Dec 31, 2025 | 9.72B | -19.63% |
| Dec 31, 2024 | 12.10B | -26.36% |
| Dec 29, 2023 | 16.43B | -8.70% |
| Dec 30, 2022 | 18.00B | 26.18% |
| Dec 31, 2021 | 14.26B | 9.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 54.72B |
| Siemens Healthineers AG | 46.92B |
| Bayer Aktiengesellschaft | 43.24B |
| Fresenius SE & Co. KGaA | 26.59B |
| Sartorius Aktiengesellschaft | 14.92B |
| Fresenius Medical Care AG | 10.38B |
| Fielmann Group AG | 3.48B |
| Carl Zeiss Meditec AG | 2.45B |